0000950123-16-016121.txt : 20160502
0000950123-16-016121.hdr.sgml : 20160502
20160502115114
ACCESSION NUMBER: 0000950123-16-016121
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160502
DATE AS OF CHANGE: 20160502
EFFECTIVENESS DATE: 20160502
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Fund Management, LLC
CENTRAL INDEX KEY: 0001637359
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16844
FILM NUMBER: 161610580
BUSINESS ADDRESS:
STREET 1: 185 DARTMOUTH STREET, SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617 502 6538
MAIL ADDRESS:
STREET 1: 185 DARTMOUTH STREET, SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Omega Fund Management (US) Inc.
DATE OF NAME CHANGE: 20150320
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001637359
XXXXXXXX
03-31-2016
03-31-2016
Omega Fund Management, LLC
185 Dartmouth Street, Suite 502
Boston
MA
02116
13F HOLDINGS REPORT
028-16844
N
Anne-Mari Paster
Chief Financial Officer, Omega Fund Management, LLC
617.502.6538
/s/ Anne-Mari Paster
Boston
MA
04-28-2016
0
11
144173
false
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
CymaBay Therapeutics
Common Stock
23257D103
818
606100
SH
SOLE
606100
0
0
Dicerna Pharmaceuticals
Common Stock
253031108
1198
223457
SH
SOLE
223457
0
0
Editas Medicine
Common Stock
28106W103
3627
105007
SH
SOLE
105007
0
0
Egalet
Common Stock
28226B104
19310
2814928
SH
SOLE
2814928
0
0
ESSA Pharma
Common Stock
29668H104
5515
1696969
SH
SOLE
1696969
0
0
FibroGen
Common Stock
31572Q808
17504
822175
SH
SOLE
822175
0
0
Juno Therapeutics
Common Stock
48205A109
46832
1229512
SH
SOLE
1229512
0
0
Nabriva Therapeutics
Sponsored ADR
62957M104
10267
1145890
SH
SOLE
1145890
0
0
Paratek Pharmaceuticals
Common Stock
699374302
32447
2138872
SH
SOLE
2138872
0
0
Pieris Pharmaceuticals
Common Stock
720795103
4720
2483949
SH
SOLE
2483949
0
0
Proteon Therapeutics
Common Stock
74371L109
1935
250000
SH
SOLE
250000
0
0